首页> 外文期刊>Nanomedicine: Nanotechnology, Biology and Medicine >Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle;doxorubicin loading and in vitro and in vivo studies
【24h】

Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle;doxorubicin loading and in vitro and in vivo studies

机译:空心壳聚糖-海藻酸盐多层微胶囊作为药物传递载体;阿霉素的载量以及体内和体外研究

获取原文
获取原文并翻译 | 示例
           

摘要

We report here the loading of the antitumor drug doxorubicin (DOX) in preformed multilayer microcapsules and its application in tumor treatment assayed by in vitro cell culture and in vivo animal experiments.The microcapsules,consisting completely of polysaccharides,were fabricated by deposition of oppositely charged chitosan and alginate onto carboxylmethyl cellulose (CMC)-doped CaC03 colloidal particles in a layer-by-layer fashion,followed by cross-linking with glutaraldehyde and decomposition of the cores by disodium ethylenediaminetetraacetic acid.The microcapsules as prepared contain negatively charged CMC-either in a free state or very possibly coupled with the excess chitosan of the first layer.They showed a strong ability to accumulate the positively charged DOX with a factor of tens to hundreds;that is,the drug concentration within the microcapsules was hundreds of times higher than the feeding concentration.Confocal microscopy and transmission electron microscopy revealed homogeneous distribution of the drug.The encapsulated DOX could be released again,following a diffusion-controlled model at the initial stage.In vitro experiments showed that the encapsulated drug can effectively induce the apoptosis of HepG2 tumor cells,as shown by various microscopy techniques after acridine orange,Hoechst 33342,and osmium tetraoxide staining.By seeding the HepG2 hepatoma cells into BALB/cu mice,tumors were created for the experimental studies.The results showed that the encapsulated DOX had better efficacy than that of the free drug in terms of tumor inhibition in a 4-week in vivo culture period.
机译:我们在此报告了预先形成的多层微胶囊中抗肿瘤药阿霉素(DOX)的负载及其在体外细胞培养和体内动物实验中测定的在肿瘤治疗中的应用。微胶囊由完全相反的多糖组成,是通过沉积带相反电荷的电荷来制备的将壳聚糖和藻酸盐逐层添加到掺有羧甲基纤维素(CMC)的CaCO3胶体颗粒上,然后与戊二醛交联,再经乙二胺四乙酸二钠分解核。制得的微胶囊含有带负电的CMC-处于游离状态或极有可能与第一层的过量壳聚糖偶联。它们显示出强大的能力来积聚带正电荷的DOX,其倍数为数十至数百;也就是说,微胶囊中的药物浓度高出数百倍镜检和透射电镜观察按照最初的扩散控制模型,被包裹的DOX可以再次释放。体外实验表明,被包裹的药物可以有效地诱导HepG2肿瘤细胞的凋亡,如各种显微镜技术所证明的那样。 Ho啶橙,Hoechst 33342和四氧化染色。通过将HepG2肝癌细胞接种到BALB / c / nu小鼠中,制备了用于实验研究的肿瘤。体内培养4周内抑制肿瘤的术语。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号